Situation normale

EBVBA Dr. Françoise Sucs, oftalmoloog
 SPRL

1000 Bruxelles
Since 26/08/1999
BE0466755288
Equity
€68.2K
-2% YoY
Gross Operating Margin
€18.1K
+72% YoY
EBITDA
€16.6K
+143% YoY
Gain/Loss
€-1.7K
-108% YoY

EBVBA Dr. Françoise Sucs, oftalmoloog’s business network visualized

Explore our interactive spiderweb to visually navigate EBVBA Dr. Françoise Sucs, oftalmoloog’s entire network of mandates and participations. Get insights into both current and historical connections.

Spiderweb EBVBA Dr. Françoise Sucs, oftalmoloog
EBVBA Dr. Françoise Sucs, oftalmoloog
  • Françoise Sucs
    1180 Uccle/Ukkel
    Since 1999

Detailed insights into EBVBA Dr. Françoise Sucs, oftalmoloog’s financial history

See financial trends including, equity, operating income, profit/loss and employees of EBVBA Dr. Françoise Sucs, oftalmoloog. Compare KPI’s against similar companies. Explore financial ratios, annual accounts and much more.

Financials 1
Financials 2
Financials 3
Financials 4
2024 2023 2022 2021 2020
Equity
68.2K
69.9K
79.9K
93.6K
79.9K
Gross Operating Margin
18.1K
10.6K
28.8K
38.9K
7.7K
Gain/Loss
-1.7K
20.1K
18.1K
31.7K
3.9K

Frequently asked questions about EBVBA Dr. Françoise Sucs, oftalmoloog

  • Where is EBVBA Dr. Françoise Sucs, oftalmoloog located?

    EBVBA Dr. Françoise Sucs, oftalmoloog’s headquarters is located in Rue de l'Aurore 2 , 1000 Bruxelles.
  • Who are the directors of EBVBA Dr. Françoise Sucs, oftalmoloog?

    EBVBA Dr. Françoise Sucs, oftalmoloog’s directors include
    • Françoise Sucs
  • When was EBVBA Dr. Françoise Sucs, oftalmoloog founded?

    EBVBA Dr. Françoise Sucs, oftalmoloog was founded in 1999-08-26. EBVBA Dr. Françoise Sucs, oftalmoloog has been active for 26 years.
  • What is EBVBA Dr. Françoise Sucs, oftalmoloog’s VAT number?

    EBVBA Dr. Françoise Sucs, oftalmoloog’s VAT number is BE0466755288.
  • What is EBVBA Dr. Françoise Sucs, oftalmoloog’s juridical form?

    EBVBA Dr. Françoise Sucs, oftalmoloog’s juridical type is Société privée à responsabilité limitée (SPRL).